| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vice Chair | Grp President, Growth & Strategy | Grp President, Glbl Innov. Grp +1 more
1 company
Prabha Parameswaran last filed a Form 4 in September 2025, as Vice Chair at CL. Prabha Parameswaran's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Prabha Parameswaran's trades have earned a below-average insider score of 44/100 across 3 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -4.2%.
At the last filing, the largest reported position was 11,018 shares of CL. The CL filings lean toward selling, a net 235,043 shares.
Prabha Parameswaran has 24 Form 4 filings on record from August 2019 to September 2025, all as Vice Chair at Colgate Palmolive (CL), 2019–2025.
The 40 reported transactions were 14 tax withholdings, 8 stock awards, 7 option or other derivative awards and 6 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 6 sales worth about $18.4M.
The largest open-market sale was 64,373 shares of CL at an average $80.58 on May 8, 2023, about $5.2M. Twelve months later CL was up 17%.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from September 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2024 | CL Colgate Palmolive Co | Grp President, Growth & Strategy | Sale+OE | 56,836 | $84.02 | $4,775,377.77 | -75.3% | +13.2% | +3.1% | |
| May 8, 2023 | CL Colgate Palmolive Co | Grp President, Growth & Strategy | Sale+OE | 64,373 | $80.58 | $5,187,169.90 | -83.8% | -4.8% | +16.5% | |
| Aug 29, 2022 | CL Colgate Palmolive Co | Grp President, Growth & Strategy | Sale+OE | 48,778 | $78.80 | $3,843,564.94 | -87.8% | -3.4% | -7.1% | |
| Sep 11, 2019 | CL Colgate Palmolive Co | Grp President, Glbl Innov. & Af/ Eus | Sell | 4,221 | $71.68 | $302,579.43 | -20.1% | - | - | |
| Aug 8, 2019 | CL Colgate Palmolive Co | Grp President, Glbl Innov. & Af/ Eus | Sale+OE | 55,835 | $70.68 | $3,946,546.22 | -72.8% | - | - | |
| Aug 6, 2019 | CL Colgate Palmolive Co | Grp President, Glbl Innov. & Af/ Eus | Sell | 5,000 | $69.35 | $346,725.50 | -19.3% | - | - |